1. Market Research
  2. > All Companies
  3. > Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • October 2015
  • -
  • Global Markets Direct
  • -
  • 34 pages

Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Summary

Global Markets Direct’s, ‘Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Concert Pharmaceuticals, Inc.’s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Concert Pharmaceuticals, Inc.’s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Concert Pharmaceuticals, Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Concert Pharmaceuticals, Inc.’s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product’s developmental history and major milestones
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement
- Latest news and deals relating to the Concert Pharmaceuticals, Inc.’s pipeline products

Reasons to buy

- Evaluate Concert Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Concert Pharmaceuticals, Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Concert Pharmaceuticals, Inc.’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Concert Pharmaceuticals, Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Concert Pharmaceuticals, Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Concert Pharmaceuticals, Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues

Table Of Contents

Concert Pharmaceuticals, Inc. - Product Pipeline Review - 2015
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Concert Pharmaceuticals, Inc. Snapshot 5
Concert Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Concert Pharmaceuticals, Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Concert Pharmaceuticals, Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Out-Licensed Products 10
Out-Licensed Products/Combination Treatment Modalities 11
Concert Pharmaceuticals, Inc. - Pipeline Products Glance 12
Concert Pharmaceuticals, Inc. - Clinical Stage Pipeline Products 12
Phase II Products/Combination Treatment Modalities 12
Phase I Products/Combination Treatment Modalities 13
Concert Pharmaceuticals, Inc. - Early Stage Pipeline Products 14
Preclinical Products/Combination Treatment Modalities 14
Concert Pharmaceuticals, Inc. - Drug Profiles 15
CTP-499 15
Product Description 15
Mechanism of Action 15
RandD Progress 15
C-10355 17
Product Description 17
Mechanism of Action 17
RandD Progress 17
C-10358 18
Product Description 18
Mechanism of Action 18
RandD Progress 18
CTP-354 19
Product Description 19
Mechanism of Action 19
RandD Progress 19
CTP-656 20
Product Description 20
Mechanism of Action 20
RandD Progress 20
CTP-221 21
Product Description 21
Mechanism of Action 21
RandD Progress 21
D-Praziquantel 22
Product Description 22
Mechanism of Action 22
RandD Progress 22
Concert Pharmaceuticals, Inc. - Pipeline Analysis 23
Concert Pharmaceuticals, Inc. - Pipeline Products by Target 23
Concert Pharmaceuticals, Inc. - Pipeline Products by Route of Administration 24
Concert Pharmaceuticals, Inc. - Pipeline Products by Molecule Type 25
Concert Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action 26
Concert Pharmaceuticals, Inc. - Recent Pipeline Updates 27
Concert Pharmaceuticals, Inc. - Dormant Projects 31
Concert Pharmaceuticals, Inc. - Locations And Subsidiaries 32
Head Office 32
Appendix 33
Methodology 33
Coverage 33
Secondary Research 33
Primary Research 33
Expert Panel Validation 33
Contact Us 33
Disclaimer 34

List of Tables
Concert Pharmaceuticals, Inc., Key Information 5
Concert Pharmaceuticals, Inc., Key Facts 5
Concert Pharmaceuticals, Inc. - Pipeline by Indication, 2015 7
Concert Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8
Concert Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9
Concert Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 10
Concert Pharmaceuticals, Inc. - Out-Licensed Products/ Combination Treatment Modalities, 2015 11
Concert Pharmaceuticals, Inc. - Phase II, 2015 12
Concert Pharmaceuticals, Inc. - Phase I, 2015 13
Concert Pharmaceuticals, Inc. - Preclinical, 2015 14
Concert Pharmaceuticals, Inc. - Pipeline by Target, 2015 23
Concert Pharmaceuticals, Inc. - Pipeline by Route of Administration, 2015 24
Concert Pharmaceuticals, Inc. - Pipeline by Molecule Type, 2015 25
Concert Pharmaceuticals, Inc. - Pipeline Products by Mechanism of Action, 2015 26
Concert Pharmaceuticals, Inc. - Recent Pipeline Updates, 2015 27
Concert Pharmaceuticals, Inc. - Dormant Developmental Projects,2015 31

List of Figures
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Indication, 2015 7
Concert Pharmaceuticals, Inc. - Pipeline by Stage of Development, 2015 8
Concert Pharmaceuticals, Inc. - Monotherapy Products in Pipeline, 2015 9
Concert Pharmaceuticals, Inc. - Out-Licensed Products in Pipeline, 2015 10
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Target, 2015 23
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Route of Administration, 2015 24
Concert Pharmaceuticals, Inc. - Pipeline by Top 10 Molecule Type, 2015 25
Concert Pharmaceuticals, Inc. - Pipeline Products by Top 10 Mechanism of Action, 2015 26

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015

Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Data

Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Nonerosive Reflux Disease (NERD) Global Clinical Trials Review, H2, 2015" provides ...

Steatohepatitis Global Clinical Trials Review, H2, 2015

Steatohepatitis Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Data

Steatohepatitis Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Steatohepatitis Global Clinical Trials Review, H2, 2015" provides an overview of Steatohepatitis clinical ...

Dyspepsia Global Clinical Trials Review, H2, 2015

Dyspepsia Global Clinical Trials Review, H2, 2015

  • $ 2 500
  • Company report
  • December 2015
  • by Global Data

Dyspepsia Global Clinical Trials Review, H2, 2015 Summary GlobalData's clinical trial report, “Dyspepsia Global Clinical Trials Review, H2, 2015" provides an overview of Dyspepsia clinical trials scenario. ...

Asthma - Pipeline Review, H2 2015

December 2015 $ 2 500

ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.